June Sherie Almenoff, Director at Ohr Pharmaceutical Inc (OHRP), bought 3,200 shares at $8.34 ($27K) on 2014-06-26, disclosed to the SEC on 2014-06-30.
Open-market purchase of $27k OHRP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| BCLI | BUY | 2019-01-08 | $5K | — | Filing → |
| INNT | BUY | 2018-08-28 | $7K | — | Filing → |
| OHRP | BUY | 2015-02-10 | $41K | — | Filing → |